From: Adenoma malignum of the uterine cervix: report of four cases
Type of surgery | Adjuvant treatment | Survival | |
---|---|---|---|
Lim et al. (18 cases)[5] | Type I RH (5/18) | None | |
Type I RH + PLND (5/18) | None | Mean follow-up period: 49.2 months | |
Type III RH + PLND (8/18) | CCRT (4/8) | Progression: 2/18 Death: 2/18 | |
ERT (3/8) | |||
CTx (1/8) | |||
Ryuichi et al. (4 cases)[18] | RH | ERT + CTx | 5 years |
ERT + CTx | |||
RH + omentectomy | ERT | 6 months | |
RH | 36 months | ||
Lymph node dissection | 15 months | ||
Bulmer et al. (2 cases)[19] | RH + PLND | None | 3 years |
Vaginal TH | ERT | 7 years | |
Gotoh et al. (1 case)[3] | TH | None | 2 years (NED) |
Koo et al. (1 case)[20] | RH | CTx | 12 months (NED) |
Chang et al. (5 cases)[7] | None | ERT | 6 months (DOD) |
RH | ERT + CTx | 46 month (DOD) | |
TH | ERT + CTx | 18 months (DOD) | |
RH | ERT | 5 years (NED) | |
RH | ERT + CTx | 3 years (NED) | |
Ki et al. (4 cases) | TH + BA | None | 14 years (NED) |
TH + BA | None | 6 years (NED) | |
Type I RH + pelvic lymph node sampling | None | 33 months (NED) | |
TH + PLND | None | 5 months (NED) |